| 前收盘价格 | 29.81 |
| 收盘价格 | 29.48 |
| 成交量 | 668,796 |
| 平均成交量 (3个月) | 1,706,254 |
| 市值 | 4,781,278,720 |
| 市盈率 (P/E TTM) | 12.90 |
| 预期市盈率 (P/E Forward) | 20.37 |
| 价格/销量 (P/S) | 3.26 |
| 股市价格/股市净资产 (P/B) | 3.64 |
| 52周波幅 | |
| 利润日期 | 13 Feb 2025 - 17 Feb 2025 |
| 营业毛利率 | 22.15% |
| 营业利益率 (TTM) | 27.70% |
| 稀释每股收益 (EPS TTM) | 2.29 |
| 季度收入增长率 (YOY) | -0.70% |
| 季度盈利增长率 (YOY) | 93.40% |
| 总债务/股东权益 (D/E MRQ) | 28.33% |
| 流动比率 (MRQ) | 3.45 |
| 营业现金流 (OCF TTM) | 355.96 M |
| 杠杆自由现金流 (LFCF TTM) | 162.09 M |
| 资产报酬率 (ROA TTM) | 8.98% |
| 股东权益报酬率 (ROE TTM) | 29.23% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (US) | 混合的 | 混合的 |
| Drug Manufacturers - Specialty & Generic (全球的) | 混合的 | 混合的 | |
| 股票 | Alkermes plc | 看跌 | 看涨 |
AIStockmoo 评分
0.4
| 分析师共识 | 1.5 |
| 内部交易活动 | NA |
| 价格波动 | -0.5 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.38 |
|
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Core |
| 内部持股比例 | 1.30% |
| 机构持股比例 | 113.80% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 43.00 (Cantor Fitzgerald, 45.52%) | 购买 |
| 中 | 37.00 (25.21%) | |
| 低 | 26.00 (JP Morgan, -12.01%) | 保留 |
| 平均值 | 35.57 (20.37%) | |
| 总计 | 5 购买, 2 保留 | |
| 平均价格@调整类型 | 26.87 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Mizuho | 13 Nov 2024 | 40.00 (35.36%) | 购买 | 29.24 |
| Stifel | 05 Nov 2024 | 36.00 (21.83%) | 购买 | 28.37 |
| Cantor Fitzgerald | 25 Oct 2024 | 43.00 (45.52%) | 购买 | 26.09 |
| 10 Oct 2024 | 48.00 (62.44%) | 购买 | 27.37 | |
| Goldman Sachs | 25 Oct 2024 | 30.00 (1.52%) | 购买 | 26.09 |
| HC Wainwright & Co. | 25 Oct 2024 | 37.00 (25.21%) | 保留 | 26.09 |
| 14 Oct 2024 | 37.00 (25.21%) | 保留 | 29.05 | |
| JP Morgan | 25 Oct 2024 | 26.00 (-12.01%) | 保留 | 26.09 |
| Piper Sandler | 25 Oct 2024 | 37.00 (25.21%) | 购买 | 26.09 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合